1-1 of 1
lymphoma, t-cell, hepatosplenic
Close
Sort by
Journal Articles

Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma

Clinical Trials & Observations
Yana Pikman, Amy Saur Conway, Amanda L. Robichaud, Samuel Kitara, Alanna J. Church, Alyssa L. Kennedy, Lewis B. Silverman, Amy L. Billett, David M. Weinstock, Marian H. Harris, Kimberly Stegmaier
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1265–1269.
https://doi.org/10.1182/bloodadvances.2019001256
Published: 2020